Brittaney Klocek is a Clinical Site Lead at Novo Nordisk with more than a decade of experience in clinical research, spanning site operations, start‑up, monitoring, and sponsor oversight. In her current role, Brittaney oversees site performance across the full clinical trial lifecycle, with a strong focus on start‑up excellence, risk mitigation, quality, and collaborative problem‑solving with global and regional partners.
Brittaney is widely recognized for her subject matter expertise in site start‑up and site learning, having served as a Subject Matter Expert for Site Initiation Visits (SIV), Site Selection Visits (SSV), and trial training programs. She has led multiple cross‑functional initiatives aimed at improving site efficiency, reducing training burden, and strengthening site–sponsor partnerships, including contributions to global training strategies and innovation projects.
Prior to her sponsor-side roles, Brittaney worked at the site level, including leadership positions in oncology and early‑phase research, which grounds her approach in practical, site‑centric solutions. She is passionate about elevating the site voice, fostering transparent communication, and advancing sustainable trial operations that benefit both sites and patients. Brittaney is an active mentor and frequent presenter at industry forums, sharing best practices to improve start‑up and trial execution.